Biohaven's drug for a genetic disease that affects the nervous system met the main study goal, sending its shares up more ...

Biohaven Ltd. (NYSE: BHVN) (Biohaven or the Company), today announced positive topline results from pivotal Study BHV4157-206 ...

XPOVIO® is the first and only approved XPO1 inhibitor in Thailand. XPOVIO® has been approved for multiple indications in nine markets across the APAC region. Antengene has submitted a new drug applica ...

Researchers from Stanford University and Rensselaer Polytechnic Institute have developed an advanced AI model that improves ...

More and more research suggests that gut microbiome metabolites could hold the key to treating nearly every disease.

Arrangement to establish a new semiconductor fabrication plant on advanced sensing, power electronics for national security, ...

Mozilla said it received almost 200 applications from innovators who’re passionate about open-source AI. What sets these AI ...

A fresh attempt is being made to build a new car showroom in Oranmore. Sean Fleming Motors was refused permission last month ...

But behind the scenes, the trend will be towards AI that enhances our lives in more subtle, seamless ways. AI tools and applications will become more integrated into the way we live and work, letting ...

The Food and Drug Administration had recently approved a new drug for the treatment of atopic dermatitis (eczema), which can significantly improve symptoms.

There hasn’t been a new class of drugs approved to help smokers quit since Pfizer's Chantix reached the market nearly two ...

This week's healthcare newsletter looks at the prospect for prior authorization reform for prescription drugs and a major FTC ...